Related Experiment Video

Updated: Oct 10, 2026

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia
10:35

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia

Published on: September 20, 2015

MRI and 18F-fluorodeoxyglucose positron emission tomography in hemimegalencephaly

K T Hoffmann1, H Amthauer, T Liebig

  • 1Department of Radiology, Virchow-Klinikum, Charité, Humboldt-University, Berlin, Germany. karl-titus.hoffmann@charite.de

Neuroradiology
|December 8, 2000
PubMed

Insights

Hemimegalencephaly, a rare brain malformation, was identified in a woman with intellectual disability and epilepsy. Positron-emission tomography (PET) revealed reduced glucose metabolism in the affected hemisphere, aiding diagnosis.

Area of Science:

  • Neurology
  • Neuroimaging
  • Medical Diagnostics

Background:

  • Hemimegalencephaly is a congenital brain malformation characterized by unilateral enlargement of the cerebral hemisphere.
  • It is often associated with neurological deficits, including intellectual disability, epilepsy, and motor impairments.
  • Accurate diagnosis and understanding of the underlying pathophysiology are crucial for patient management.

Observation:

  • A 44-year-old woman presented with a history of mental retardation, epilepsy, and mild hemiparesis.
  • Magnetic Resonance Imaging (MRI) revealed findings consistent with hemimegalencephaly.
  • 2-deoxy-2[18F]fluorodeoxyglucose Positron-Emission Tomography (PET) was employed for functional assessment.

Findings:

  • PET imaging demonstrated significant glucose hypometabolism in the hemisphere affected by hemimegalencephaly.
  • This functional deficit correlated with the structural abnormalities observed on MRI.
  • Image fusion of PET and MRI data provided a comprehensive view of both structural and metabolic changes.

Implications:

  • Positron-emission tomography (PET) can effectively identify functional deficits in hemimegalencephaly, complementing structural MRI.
  • The coregistration of PET and MRI data enhances diagnostic accuracy and aids in understanding the pathophysiology of neurological deficits.
  • This integrated imaging approach may inform treatment strategies and prognostication for patients with hemimegalencephaly.

More Related Videos

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...